Abstract
Health insurers have a unique opportunity to leverage Healthtech startups. This report series looks at a cross-section of interesting companies across a spectrum defined by our parent company Oliver Wyman's Health and Life Sciences practice. This is the fourth in a series of five reports from and authored by Celent.
In this report we focus on Tech and Funding. This is the critical topic we discuss with health insurers. The startups and established vendors profiled here are innovating for the benefit of the entire value chain.
As mentioned in the overview report, in each area, we will look at a variety of healthtech firms delivering interesting and useful technology to improve each functional area. There are literally thousands of these companies, which is encouraging for our industry. Clearly we will look at a cross-section.
As always, feedback is welcome!
Table of contents
| 1 | Overview |
| 2 | Example Vendors |
| 3 | Path Forward |